This article focuses on new antithrombotic drugs that are in or are entering phase 3 clinical
testing. Development of these new agents was prompted by the limitations of existing …

This chapter focuses on new antithrombotic drugs that are in phase II or III clinical testing.
Development of these new agents was prompted by limitations of existing antiplatelet …

CHEST Skip to Main Content Advertisement CHEST home Submit Log in Register Log in
Submit Log in Subscribe Claim Skip menu Articles Cover Image - CHEST, Volume 164, Issue 6 …

The Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of
Chest Physicians Evidence-Based Clinical Practice Guidelines differs substantially from the …

Thrombosis, an important complication of atherosclerosis and of various medical and
surgical conditions, can be prevented or treated effectively by a variety of pharmacologic …

This article about new anticoagulant drugs is part of the seventh American College of Chest
Physicians Conference on Antithrombotic and Thrombolytic Therapy: Evidence-Based …

Thrombosis can be prevented and treated effectively by a variety of pharmacologic agents.
This monograph provides a summary of the 2003 American College of Chest Surgeons …

Background To develop the Antithrombotic Therapy and Prevention of Thrombosis, 9th ed:
ACCP Evidence-Based Clinical Practice Guidelines (AT9), the American College of Chest …

Since publication of the seventh American College of Chest Physicians (ACCP) supplement
on antithrombotic and thrombolytic therapy, the results of clinical trials have provided …

This chapter about implementation strategies for practice guidelines is part of the 7th ACCP
Conference on Antithrombotic and Thrombolytic Therapy: Evidence Based Guidelines …